Lu Zy
Impact in
- Hematology top 2%
- Multiple Myeloma Research and Treatments
- Oncology top 10%
- Cytokine Signaling Pathways and Interactions
- Chemokine receptors and signaling
- Peptidase Inhibition and Analysis
Papers in
-
- Multiple Myeloma Research and Treatments 4
- Hematopoietic Stem Cell Transplantation 1
- Oncology 4
- CAR-T cell therapy research 1
- Chemokine receptors and signaling 1
- Co-authors
- Bernard Klein (4 shared papers)Régis Bataille (3 shared papers)J Brochier (3 shared papers)JF Rossi (3 shared papers)Thierry Lavabre‐Bertrand (1 shared paper)R Bataille (1 shared paper)Tim N. Beck (1 shared paper)Bart Barlogie (1 shared paper)
- Journals
- Blood (3 papers)Bone Marrow Transplantation (1 paper)PubMed (5 papers)
In The Last Decade
Lu Zy
9 papers receiving 911 citations
Lu Zy's Hit Papers
Peers
Comparison fields: 5 of 71
- Hematology 551
- Oncology 453
- Immunology 213
- Genetics 84
- Immunology and Allergy 41
Countries citing papers authored by Lu Zy
This map shows the geographic impact of Lu Zy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu Zy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu Zy more than expected).
Fields of papers citing papers by Lu Zy
This network shows the impact of papers produced by Lu Zy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu Zy. The network helps show where Lu Zy may publish in the future.
Co-authors
The 25 scholars most cited alongside Lu Zy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Interleukin-6 in human multiple myeloma Hit paper breakdown → | 1995 | 474 |
| 2 | 1995 | 230 | |
| 3 | Interleukin-6 is the central tumor growth factor in vitro and in vivo in multiple myeloma. | 1991 | 113 |
| 4 | 1995 | 86 | |
| 5 | 2001 | 33 | |
| 6 | Epitope analysis of human IL-6 receptor gp80 molecule with monoclonal antibodies. | 1994 | 16 |
| 7 | [Cultural perspectives of health and illness in the context of nursing]. | 1996 | 8 |
| 8 | 2016 | 1 | |
| 9 | [Effects of tachykinin receptor antagonists on allergic asthma in guinea pigs]. | 1997 | 1 |
About Lu Zy
Lu Zy is a scholar working on Hematology, Oncology, Immunology, Radiology, Nuclear Medicine and Imaging and Emergency Medicine, having authored 9 papers that have together received 962 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (4 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Glycosylation and Glycoproteins Research (1 paper), Hematopoietic Stem Cell Transplantation (1 paper), CAR-T cell therapy research (1 paper), Immunotherapy and Immune Responses (1 paper), Chemokine receptors and signaling (1 paper) and Health, Nursing, Elderly Care (1 paper). The work is most often cited by research in Hematology (551 citations), Oncology (453 citations), Immunology (213 citations), Genetics (84 citations) and Immunology and Allergy (41 citations). Lu Zy has collaborated with scholars based in France and China. Frequent co-authors include Bernard Klein, Régis Bataille, J Brochier, JF Rossi, Thierry Lavabre‐Bertrand, R Bataille, Tim N. Beck, Bart Barlogie, XG Zhang and Marie Lise Jourdan. Their work appears in journals such as Blood, Bone Marrow Transplantation and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.